Paysign Q3 2022 revenue $10.6M (+36% YoY); net income $0.85M; guides FY2022 rev $38.15-38.35M

Paysign, Inc.

2022-Q3 EPS reported $0.01 revenue$27,415,843

Revenue $10.6M (+36% YoY); net income $0.85M vs loss of $0.27M in Q3 2021; diluted EPS $0.02.
Adjusted EBITDA $1.9M ($0.04 per diluted share); gross margin improved to 54%.
FY2022 revenue guidance $38.15M-$38.35M (29-30% growth); adjusted EBITDA expected $5.50-$5.60M.
Added 13 plasma donation centers in Q3, ending with 450 centers; plasma revenue up 40% YoY.
Unrestricted cash $8.0M; federal injunction allows Mexican nationals to donate plasma again.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.85

Paysign, Inc. reported third quarter of 2022 results: revenue $10.6 million, net income $0.85 million, EPS $0.02.

Period: third quarter of 2022
Revenue: $10.6 million
Net income: $0.85 million
EPS: $0.02
Result: reported results

Exact text from the filing

EX-99.1 (PRESS RELEASE) --- EX-99.1 2 paysign_ex9901.htm PRESS RELEASE Exhibit 99.1 Paysign, Inc. Reports Third Quarter 2022 Financial Results · Third quarter total revenues of $10.6 million, an increase of $2.8 million (36.4%) from third quarter 2021 · Third quarter net income of $0.85 million, or diluted earnings per share of $0.02 · Third quarter Adjusted EBITDA

View on SEC.gov

Browse all earnings releases →

Paysign, Inc. filing history →

Source: SEC EDGAR

accession 0001683168-22-007393

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.